This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

National Institute Of Health Selects Booz Allen As CIO-SP3 Awardee

Booz Allen Hamilton (NYSE: BAH) has been selected by the National Institutes of Health (NIH) as an awardee for the agency’s Chief Information Officers Solutions and Partners 3 (CIO-SP3) Government-Wide Acquisition Contract (GWAC). The contract, administered by NIH’s Information Technology Acquisition and Assessment Center (NITAAC), is a 10-year Indefinite Delivery, Indefinite Quantity contract valued up to $20 billion for all awardees.

Under the contract, Booz Allen can compete for individual task orders from federal agencies to provide a wide range of services that support federal IT architectures including: IT services for biomedical research, health sciences and healthcare, imaging, IT operations and maintenance, integration services, and software development.

“Federal agencies need access to leading IT technology and services to meet the maturing and evolving needs of the citizens they serve,” said Susan Penfield, Senior Vice President, Booz Allen Hamilton. “The CIO-SP3 provides federal agencies a competitive contract to access the right IT services and solutions needed – quickly and efficiently.”

Booz Allen’s deep and broad expertise in technology, specifically as it relates to health and health IT, is drawn from years of working with the federal government to address their technology challenges. This technical expertise spans across CIO-SP3’s 10 task areas.

The CIO-SP3 GWAC is available to all federal agencies that need IT solutions and services, including the Department of Defense. Booz Allen was an awardee under CIO-SP2, the preceding contract vehicle, for the previous 10 years.

Forward Looking Statements

This press release contains, or may be deemed to contain, “forward-looking statements” (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Examples of forward-looking statements include information concerning the value of the contract award and Booz Allen Hamilton’s future performance under the contract. These statements give Booz Allen Hamilton’s current expectation of future events or its future performance and do not relate directly to historical or current events. A number of factors could cause Booz Allen Hamilton’s future actions and related results to vary from any expectations or goals expressed in, or implied by, the forward-looking statements included in this press release, possibly to a material degree. Some of these factors include, but are not limited to, the risk factors set forth in Booz Allen Hamilton’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on June 8, 2011. All forward-looking statements included in this press release speak only as of the date made, and, except as required by law, Booz Allen Hamilton undertakes no obligation to update or revise publicly any such forward-looking statements, whether as a result of new information, future events, or otherwise.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs